Skip to main content
Division of Cancer Prevention
Search form
Search
Making cancer prevention possible
Main menu
Home
Major Programs
Cancer Prevention Fellowship Program (CPFP)
Early Detection Research Network (EDRN)
NCI Community Oncology Research Program (NCORP)
Alliance of Glycobiologists for Cancer Research
Barrett's Esophagus Translational Research Network (BETRNet)
Cancer Prevention Clinical Trials Network (CP-CTNet)
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
Consortium for Imaging and Biomarkers (CIB)
HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
Liquid Biopsy Consortium
NCI Cervical Cancer ‘Last Mile’ Initiative
Pancreatic Cancer Detection Consortium (PCDC)
Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
PREVENT Cancer Preclinical Drug Development Program (PREVENT)
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
Small Cell Lung Cancer (SCLC) Consortium
Supportive Care and Symptom Management
Translational Liver Cancer (TLC) Consortium
US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
Research Networks Map
Research Groups
Biometry
Breast and Gynecologic Cancer
Cancer Biomarkers
Chemopreventive Agent Development
Community Oncology and Prevention Trials
Early Detection
Gastrointestinal and Other Cancers
Lung and Upper Aerodigestive Cancer
Nutritional Science
Prostate and Urologic Cancer
Clinical Trials
Clinical Trials Search
Landmark Trials
Clinical Trials Management
Why I Joined a Clinical Trial
Funding & Grants
Funding Opportunities
Funded Grants
Grantsmanship Resources
Resources
Publication Search
Biorepositories
Cancer Data Access System
News & Events
News
Blog
Meetings and Events
Videos and Webinars
Infographics
About DCP
Scientific Scope
Commemoration of the 50th Anniversary of the National Cancer Act
Director
DCP Leadership
History and Timeline
Historical Resources
Staff Directory
You are here
Home
»
Research Groups
»
Breast and Gynecologic Cancer
»
Breast and Gynecologic Cancer Staff
Section Menu
Biometry
Breast and Gynecologic Cancer
About the Breast and Gynecologic Cancer Research Group
Active Grants
Clinical Trials
Funding Opportunities
How Patients and Their Doctors Determine Cancer Risk—and What Happens Next
Making Informed Choices on Incorporating Chemoprevention Into Breast Care: Q & A with Dr. Katherine Crew on the MiCHOICE Trial
Publications
Publications
Staff
Cancer Biomarkers
Chemopreventive Agent Development
Community Oncology and Prevention Trials
Early Detection
Gastrointestinal and Other Cancers
Lung and Upper Aerodigestive Cancer
Nutritional Science
Prostate and Urologic Cancer
Contact the Breast and Gynecologic Cancer Research Group
Phone:
240-276-7051
Fax:
240-276-7828
For Regular Mail
Breast and Gynecologic Cancer Research Group, DCP, NCI
9609 Medical Center Drive
MSC 9783
Bethesda
,
MD
20892-9783
For Courier Packages
Breast and Gynecologic Cancer Research Group, DCP, NCI
9609 Medical Center Drive
Rockville
,
MD
20850
Breast and Gynecologic Cancer Staff
Mela Asefa
240-276-6422
asefamk@mail.nih.gov
Emma Brofsky, M.S.P.H.
240-276-7532
brofskyej@mail.nih.gov
Eileen Dimond, R.N., M.S.
240-276-7086
dimonde@mail.nih.gov
Brandy Heckman-Stoddard, Ph.D., M.P.H.
240-276-7048
heckmanbm@mail.nih.gov
Esmeralda Ramirez-Peña, Ph.D., M.P.H.
240-276-7006
ramirezpenaeq@mail.nih.gov
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
240-276-7332
sahasrabuddhevv@mail.nih.gov
Goli Samimi, Ph.D., M.P.H.
240-276-6582
goli.samimi@nih.gov
Edward Sauter, M.D., Ph.D.
240-276-7657
edward.sauter@nih.gov
^
Top
